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A
s both a medical student and a cancer patient, 
I found that the Pulitzer Prize–winning book 
The Emperor of All Maladies: A Biography of 
Cancer by Siddhartha Mukherjee, D.Phil., MD 
(Simon and Schuster, 2010), gave me at once a dose of 
knowledge and a salve for the soul. Early in the book, 
Dr. Mukherjee candidly writes that he started his biogra-
phy of cancer as a way, ironically, to escape his “immer-
sive”—read “drowning”—oncology fellowship. He fled 
into the annals of cancer-treatment research to make 
sense of the lethal complexity—scientific, emotional, 
and human—that he and his patients were experienc-
ing. He addresses the questions anyone with cancer can 
bat away only for so long: What is cancer? Why me? 
Years later, the finished product, a magisterial work of 
enormous research and reflection on the nature of can-
cer, has won and deserved its shower of accolades.
For Mukherjee, the modern history of cancer begins 
with Sidney Farber (of the eponymous Dana-Farber 
Cancer Institute, where Mukherjee received fellowship 
training), who warrants a book all his own. In the 1950s, 
Farber, a pathologist by training, became dissatisfied 
with the cloistered world of the lab and began his quix-
otic search for the cure for childhood leukemia, and more 
broadly, cancer itself. Taking a page from Paul Ehrlich’s 
Salvarsan, a drug developed for syphilis decades earlier 
and the first “chemotherapy,” or sought-after “magic 
bullet,” Farber dreamed of treating cancer not with the 
scalpel or the X-ray beam but with a drug, something 
that was then inconceivable, cancer being more or less 
a black box of biology at the time. This turned out to be 
a prescient dream, as Farber’s therapeutic application of 
“fake vitamins” such as aminopterin and its sister acid, 
methotrexate, allowed him to leapfrog ahead of the 
contemporary understanding of cancer’s mechanics to 
produce remissions, even cures, among a few of his first 
otherwise tragic cohort of children.
The first chapters introduce a cast of memorable charac-
ters. Mukherjee carefully marks pivotal moments in the 
history of medicine that shed light on cancer’s mystery 
for us; these chapters are enjoyable enough for newbies 
and will be relished by the well initiated. They are sign-
posts indicating entrance to a new and foreign land: we 
are introduced to Vesalius’ anatomical revolution, chal-
lenging dogma by mapping the human body and ulti-
mately unseating the vague theory of “black humours” 
Galen ascribed to cancer’s root; the discovery of the 
Rous sarcoma virus, which causes cancer in chickens, 
thus establishing a viral theory of carcinogenesis; the 
first case-control study by Hill and Doll, a maneuver to 
convince a circumspect medical community that smok-
ing played a role in lung cancer; and the first random-
ized clinical trial to establish streptomycin as an effective 
treatment for tuberculosis and the pioneering cancer tri-
als that quickly followed. Finally, Mukherjee includes the 
early days of HIV and the rabid advocacy it inspired (see, 
for example, the play The Normal Heart, which won a 
Tony in 2011). The sword cuts both ways here; scientists 
were saving lives by accelerating access to experimental 
treatments, but also setting—and years later springing—
the trap for quackery on an international scale (see Dr. 
Werner Bezwoda).
For a book aimed at relating the enormous intellectual 
challenge that cancer presents to scientists and laypeo-
ple alike, its writing retains enormous heart. The pas-
sages about patients are so personal and poignant that 
you are apt to wonder what was the last nonfiction book 
you read that provoked such an emotional response—
and at the clip of a Tom Clancy thriller. The book is in 
some respects a coming-of-age story, a bildungsroman 
of cancer culled from an assortment of vignettes and 
research (there are abundant epigrams for each chap-
ter), as cancer becomes, as Mukherjee eloquently puts 
it, “the quintessential illness of modernity,” noting that 
it was only recently unveiled by advances in science, 
hygiene, and longevity. Dr. Mukherjee lionizes patients 
who found themselves at turning points in the history 
of cancer, such as little “Jimmy” (his real name—Einar 
Gustafson—too unwieldy for a 1950s American public) 
of the Jimmy Fund, and Barbara Bradfield, who had 
resigned herself to cancer’s rapidly progressing, lethal 
endgame by retiring to Mexico before being handpicked 
to be the first to receive targeted cancer therapy using 
antibodies. Also compelling is the ripe-for-Hollywood 
tale of the young, crusading scientist Dr. Druker, with 
the cure for chronic myelogenous leukemia lying on a 
counter in his lab—the “magic bullet” that Ehrlich had 
augured almost a hundred years before—who must 
strong-arm the reluctant pharmaceutical company into 
production of what would become the wonder drug 
Gleevec, which exceeded $1 billion in revenue last year. 
Long periods of darkness, of course, overshadow these 
blips of success. The history of cancer treatment has, by 
and large, been a long, sad, and mostly failing story. The 
earliest reference to cancer, in 1600 B.C., by the Egyptian 
physician Imohtep, sums up the patient’s fate grimly: 
“For this, there is no treatment.” This terse statement 
effectively became the standard of care for the next few 
millennia. With advances in surgery at the end of the 
1800s, cancer treatment underwent a reappraisal. One 
ambitious surgeon, Dr. William Halsted—perhaps the 
book’s villain, if a human and tragic one—pioneered the 
most aggressive surgical treatment for breast cancer, the 
radical mastectomy. While improved surgical techniques 
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provided an inroad to treating these tumors, Halsted’s 
extreme technique turned out to be more disfiguring 
than therapeutic, and when he was faced with evidence 
of that, he deluded himself and retreated into alternat-
ing heroin and cocaine addictions. 
Dr. Mukherjee’s experience in the wards provides a hand-
ful of cameos, not only presenting him as a sort of Virgil 
to cancer’s Inferno, describing the many hellish treat-
ments that were used during the evolution of oncology, 
but also as a father, at the birth of his first child, and as a 
fellow, with vignettes of his own from the wards. These 
experiences set an expansive stage where cancer plays its 
role as antagonist and protagonist throughout ancient 
and modern medical history. 
Mukherjee saves his best device for last, moving through 
the centuries with the story of Atossa, a Persian queen 
from 300 B.C. with breast cancer, as “cancer’s Dorian 
Grey,” following the progression of treatment from 
her own time (essentially, a brutal mastectomy) to the 
care she would have received in Halsted’s day, also radi-
cal and disfiguring, to the treatment she would receive 
today: evidence-based surgical techniques, radiation, 
hormone and targeted therapy, along with a battery 
of screening measures based on her ethnic background 
and age, aimed at early detection and intervention for 
BRCA mutations. He also muses on a tantalizing future 
of individual patients’ sequenced cancer genomes on 
flash drives, put into algorithms and matched to cus-
tomized treatment regimens. But Mukherjee tempers 
his optimism, pointing out that with some kinds of can-
cer, such as pancreatic, the improved survival is mea-
sured in months, scarcely enough time for the requisite 
bookkeeping of our modern lives before we shuffle off 
the mortal coil. “Onkos (for oncology) arises from the 
ancient word nek,” Mukherjee writes at the book’s con-
clusion, which means “to carry, to move the burden from 
one place to the next, to bear something across a long 
distance and bring it to a new place. It is an image that 
captures not just the cancer cell’s capacity to travel—
metastasis—but also Atossa’s journey, the long arc of 
scientific discovery—and embedded in that journey, the 
animus, so inextricably human, to outwit, to outlive, 
and survive.” By the end, Mukherjee has done more 
than simply tell the story of cancer; he has identified the 
struggle against cancer as something profoundly human 
and dignified and timeless, if no less tragic.
Corresponding Author: Christopher Beaudoin, BA (christopher.beaudoin@
med.einstein.yu.edu). 
 
Conflict of Interest Disclosures: The author has completed and submitted the 
ICMJE Form for Disclosure of Potential Conflicts of Interest. No conflicts were 
noted.
4BOOK REVIEW
